Source Archive
Selected regulatory analysis, source materials, prior work artifacts, and historical policy documents that help inform Pegasus Health Institute's research agenda. Some items reflect work completed before Pegasus and are included for transparency and context.
Selected Source Materials
This archive organizes selected policy materials, regulatory comments, historical work products, and reference documents that help inform Pegasus's research agenda. For current long-form analysis, read Pegasus commentary.
Marketplace Mismanagement: Broker & Consumer Harm
A detailed exposé on how lax CMS enforcement allows fraudulent actors to thrive in the ACA Marketplace, displacing ethical brokers and putting consumers at risk.
Systemic failures in broker oversight
Data on wrongful broker terminations
Abuse of EDE pathways by large firms
Policy recommendations for enforcement reform
CMS 2024 NBPP Comments
Formal comments to CMS regarding proposed changes in the 2024 Notice of Benefit and Payment Parameters, with focus on consumer protections, mapping rules, and Navigator governance.
Concerns over auto-enrollment into zero-premium plans
Income reconciliation flexibility proposals
Navigator vs. Broker authority inequities
Support for transparent annual mapping logic
Summary of the 2024 NBPP Final Rule
A plain-language guide to the finalized 2024 NBPP rule, highlighting implications for brokers, carriers, and consumers in the ACA Marketplaces.
Network adequacy enforcement for all QHPs
Nonstandard plan ratio limitations
Revisions to mid-month SEP rules
Consumer protections for plan display errors
Comments on CMS-28317 (NBPP 2023)
Policy commentary on the 2023 NBPP Proposed Rule, including concerns about past due premium clawbacks, income projection liabilities, and web-broker ethics.
Critique of insurer authority to claw back unpaid premiums
Support for stronger ethics in plan recommendation algorithms
Agent liability in income projection for APTC
Risks from misaligned QHP mapping
STLDI Proposed Rule Overview
A summary of the proposed rule tightening Short-Term Limited Duration Insurance (STLDI) and Fixed Indemnity rules to protect consumers and stabilize the ACA market.
Limits on duration and stacking of STLDI policies
Marketing transparency and disclosure mandates
Broker commission conflicts of interest
STLDI’s effect on ACA risk pools
STLDI and Fixed Indemnity Final Rule Summary
A final review of changes to Short-Term Limited Duration and Fixed Indemnity plans, with compliance timelines and guidance for brokers.
New duration caps and stacking prohibitions
Required consumer disclosures in marketing
Broker education and advocacy guidance
Implementation deadlines for insurers
Senate Finance Committee Commentary
Discussion of marketing abuses in senior markets, SHIP funding conflicts, and the need for centralized Medicare oversight.
Systemic Medicare Advantage marketing flaws
Conflict of interest in SHIP funding
Oversight gaps between CMS and states
Recommendations for consumer protection reforms
PAHA Comments on CMS-13993
Feedback on ACA rulemaking related to Navigators, SEP design, equity initiatives, and support for underserved consumer segments.
SEP enhancements and navigator limitations
Support for racial equity and health literacy
MAGI income misinterpretation case studies
Need for clearer plan branding and outreach
Race & Ethnicity Question Guidance
Tips for addressing consumer concerns about race and ethnicity questions on Marketplace applications, with privacy reassurances and outreach best practices.
Clarification of optional demographic questions
Impact of responses on policy development
Assurances of privacy and non-impact on eligibility
Guidance for brokers and assisters
Clarifying Agent/Broker Roles – SB1222
Commentary on Pennsylvania’s SB1222 and a request to distinguish broker responsibilities from carrier-tied agents in proposed regulatory language.
Advocacy for broker independence
Distinguishing brokers from carrier-tied agents
Retail analogy for insurance industry structure
Suggested legislative clarifications for SB1222
Pegasus Health Institute is informed by prior healthcare policy, media, consumer assistance, and market analysis work led by Joshua Brooker and related initiatives. This archive includes selected media citations, source materials, regulatory engagement, and policy frameworks that help shape Pegasus's ongoing research agenda. Where materials originated in another organizational context, that context is noted for transparency, continuity, and historical reference only.
Insights and source materials are provided for educational and informational purposes only. Some materials reflect prior work performed under, alongside, or in connection with other organizations, brands, or initiatives. Other materials may reflect Pegasus Health Institute publications, collaborations, sponsorships, or material partnerships, where clearly identified. Inclusion of an organization's name does not imply endorsement, representation, retention, sponsorship, or approval unless expressly stated. These materials do not constitute legal, investment, tax, actuarial, lobbying, or pay-to-play policy access services.